BQE heads into the final days of April carrying momentum that few micro-cap environmental services names generate — a 27% one-month rally, a 9-11% post-earnings gap, and a borrowing market that has grown measurably more expensive in recent weeks.
The catalyst is clear. BQE reported full-year 2025 results on April 23rd that doubled GAAP revenues to CAD 35.5 million, lifted net income 68% to CAD 8.1 million, and closed the year with CAD 19 million in cash — a working capital base up 70% year-over-year. CEO David Kratochvil described the year as "transformational," pointing to an operations team that has tripled in headcount, a new aquatic toxicity lab nearing completion, and an engineering backlog he called the deepest he has seen. The stock responded: it closed April 24th up roughly 9.6% and added another 2.5% on April 28th to reach CAD 82.
The borrow market tells the more interesting story this week. Cost to borrow has tripled since February, climbing from roughly 2.2% to 13.4% — the highest level of the past six months. That rise tracks the sharp jump in short positions: estimated shares short more than tripled between April 17th and April 21st, going from around 272,000 shares to 937,000 shares, and have held near that level since. Short interest remains modest in absolute terms at under 0.1% of free float, but the speed of the build is unusual for a name this small. Availability has tightened as a consequence — roughly 41% of lendable supply is now deployed, down from under 13% through most of February and March. The 52-week peak in borrowing intensity hit 100%, so there is room to tighten further. At the current level it suggests a crowded but not yet stressed borrow situation, with the cost of being short rising meaningfully for anyone establishing a new position into strength.
The ORTEX short score has oscillated around 50 this week, settling at 49.9 on April 28th — a middling reading that reflects the push-pull between heavy recent positioning and the easing of shares short from the mid-week peak. The days-to-cover figure of 1.17 (per official FINRA data as of April 15th) is low enough that there is no structural short-squeeze pressure. What the data does show is a subset of investors willing to bet against a stock trading at its 12-month high immediately after a strong earnings print, a posture that typically reflects either a view that the results were one-off in nature or that the valuation has run ahead of the underlying earnings power.
Ownership is tightly held. The two largest shareholders — Richard Hubbard and Hall Tingley — together hold roughly 35% of shares. Tingley, a 10% owner, was a buyer in the CAD 49-50 range in April and May 2025, well below the current price. The most recent insider activity on record is a VP-level purchase at CAD 51.50-54.30 last September. No insider sales are on file for the past year, though the data extends only to September 2025. That absence of selling into the rally is worth noting in a micro-cap where insider distribution can be a reliable early signal.
The next scheduled results are due May 28th. With the full-year print already digested and the stock trading near all-time highs, the question at that quarterly update will be less about whether 2025 was genuinely strong — it was — and more about whether the chemical services revenue from Yukon that contributed roughly CAD 20 million in 2025 can be sustained or replaced, and whether the newly enlarged operations team delivers the recurring revenue growth management is targeting for 2026.
See the live data behind this article on ORTEX.
Open BQE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
